This page is being managed directly by the hospital. Any communications initiated will be responded to directly by the hospital.

Na Homolce Hospital

Hlavní město Praha, Czechia


Foundation year




Medical staff

All / Top Specialties

  • Vestibular schwannoma

  • Robot-Assisted Surgery

  • Hypertensive Heart Disease

  • Sepsis

  • Thoracic aortic aneurysm

  • Critical Limb Ischemia (CLI)

  • Pituitary Tumors

  • Minimally Invasive Cardiac Surgery

  • Vascular Malformations

  • Hernia Repair

  • Ventricular Systolic Dysfunction

  • Thoracic Endovascular Aortic Repair (TEVAR)

  • Epilepsy

  • Adrenal Gland Surgery

  • Congenital Heart Diseases

  • Endovascular surgery

  • Chronic Heart Failure

  • Cerebral Aneurysm

  • Hip and Knee Surgery

  • Transcatheter Aortic Valve Implantation (TAVI)

  • Video-assisted Thoracoscopic Surgery

All / Top Services

  • Brain Tumors

  • Meningiomas

  • Spinal cord tumours

  • Robot-Assisted Surgery

  • Robotic heart surgery

  • Robot-assisted surgical revascularization

  • Restorative procedures

  • Closures of atrial septal defects

  • Hypertensive Heart Disease

  • Thoracic aortic aneurysm

  • Surgery of arteries of the lower limb including their peripheral sections

  • Endoscopic technique

  • Minimally Invasive Cardiac Surgery

  • Arteriovenous malformations

  • Cerebral cavernomas

  • Revascularization surgery

  • Ventricular Systolic Dysfunction

  • Thoracic aortic surgery

  • Subrenal aortic and pelvic bed surgery

  • Complex solution of aortic aneurysms in all sections

Contact Information

2 37 Roentgenova Praha 5 Hlavní město Praha Hlavní město Praha Czechia


Na Homolce Hospital is a clinical healthcare facility directly managed by the Ministry of Health of the Czech Republic. It is a specialized hospital that focuses on providing exceptionally qualified and technologically advanced treatment for cardiovascular and neurological diseases, as well as neurosurgical interventions. Unlike large teaching hospitals, Na Homolce Hospital does not offer a complete spectrum of medical services but specializes in specific fields. The hospital does not have a catchment area for patient selection. Instead, it accepts patients from all over the country or abroad based on recommendations from general practitioners and specialists. Na Homolce Hospital is recognized as a scientific and research workplace and holds the prestigious SAK accreditation, which ensures a high level of care and patient safety. The mission of Na Homolce Hospital is to assist patients in managing health problems, particularly serious heart, blood vessel, and nervous system diseases, with the ultimate goal of improving their quality of life. The hospital's specialization and comprehensive approach enable it to deliver services at the highest level. The hospital successfully defended its SAC accreditation, which was obtained following an investigation by the Joint Accreditation Commission. This accreditation certifies that Na Homolce Hospital meets all the standards of quality and safety in healthcare provision as mandated by relevant regulations and laws. Petr Polouček, MBA, the director of the hospital, expressed his satisfaction with the accreditation, highlighting the professionalism of the hospital's employees as the key factor in this success. Here is a timeline of significant events and achievements in the history of Na Homolce Hospital: 1990: Na Homolce Hospital is established. 1996: The hospital performs the first insertion of a stent graft into an abdominal aortic aneurysm. Angioline installation and the first interventions on the coronary arteries also take place. 1997: The hospital carries out its first catheter ablation procedure. 1998: Aneurysm of the cerebral artery is operated using the endovascular method for the first time at the hospital. The first intra-arterial thrombolysis in stroke and deep brain stimulation (DBS) for the treatment of Parkinson's disease in the Czech Republic are also performed. 2001: The hospital conducts its first arterial graft transplant and implants a spinal neurostimulator for refractory angina, a first in the country. Additionally, the hospital performs catheter ablation in a functional epicardial manner for the first time. 2002: The disciplines of cardiac surgery and vascular surgery are divided into separate entities. 2004: Na Homolce Hospital achieves several world premieres, including the treatment of malignant brain tumors using the TTF method (Optune), cryobalone catheter ablation, and prevention of ischemic stroke occlusion by using a left cardiac network occluder. The hospital initiates lung surgery and thoracic surgery and opens an outpatient oncology department. 2006: The hospital establishes a center for adult patients with congenital heart disease and a Laboratory of Molecular Diagnostics. They also perform the world's first robotic surgery for an abdominal aortic aneurysm. 2008: Na Homolce Hospital successfully defends international accreditation from JCI (Joint Commission International) and opens a complex of three multifunctional catheterization rooms equipped with robotic systems. The hospital introduces magnetic and mechanical robotic navigation into catheter treatment of cardiac arrhythmias, a first in the Czech Republic. A new intensive care unit is opened in the neurosurgical department, and an experimental laboratory of the joint workplace of the 1st Faculty of Medicine, Charles University is inaugurated. 2009: The hospital opens a new complex of neurosurgical operating theaters with peroperative magnetic resonance imaging. They perform the first robotic heart surgery in the Czech Republic and attain the status of a Comprehensive Cardiovascular Center. 2012: The hospital implants a wireless pacemaker for the first time, and bronchial thermoplasty is introduced for the treatment of severe asthma, a first in Central Europe. 2013: Na Homolce Hospital achieves a world premiere by performing heart valve surgery using catheter technique. 2014: The hospital performs surgery on heart ventricular aneurysm using a hybrid method of cardiac surgery and cardiology. They also obtain JCI accreditation. 2016: A hybrid multidisciplinary workplace equipped with the next-generation Da Vinci Xi operating robot is opened, along with an ultrasonographer at the department of neurosurgery. 2017: The hospital successfully defends international accreditation from JCI again and acquires a new PET/CT scanner. They also perform 400 robotic vascular surgeries, a global first. 2018: Na Homolce Hospital opens a new pharmacy and installs a new angioline connectable with CT. They achieve the world's first implantation of microfilters into the carotid artery to capture blood clots and obtain the Diamond status of the Comprehensive Cerebrovascular Center. 2020: The hospital celebrates its 500th robotic vascular surgery and establishes the Statute of the Centre of Highly Specialized Oncological and Haemato-Oncological Care. They also obtain SAK accreditation. 2021: Na Homolce Hospital introduces a new technology for the treatment of cardiac arrhythmia using irreversible electroporation Anti-corruption strategy Based on the Order of the Minister of Health No. 22/2019 and Government Regulation No. 145/2015 Coll., the Management Meeting approved a new Internal Anti-Corruption program (hereinafter referred to as the "Programme") on August 27. The management of Na Homolce Hospital (hereinafter referred to as the Hospital), by approving the Program: makes it clear that the Hospital is committed to preventing corruption and applying the principle of zero tolerance to it; undertakes to act honestly, fairly, and openly at all times; promotes a culture across the Hospital in which corruption is by no means acceptable; is responsible for the effective implementation of the Program. In this context, we would like to inform you that you have the opportunity to report suspected corrupt conduct in the manner specified in the Suspected Wrongdoing section. The hospital is committed to ensuring anonymity for whistleblowers and protection against retaliation. Na Homolce Hospital (hereinafter referred to as the "Hospital") undertakes to make its website accessible in accordance with the accessibility rules pursuant to Directive (EU) 2016/2102 of the European Parliament and of the Council of October 26, 2016 on the accessibility of websites and mobile applications of public sector bodies and the obligations arising from Act No. 99/2019 Coll., on the accessibility of websites and mobile applications, and amending Act No. 365/2000 Coll., on public administration information systems, and on amendments to certain other acts, as amended (hereinafter referred to as the "Accessibility Act"). Na Homolce Hospital meets the conditions of the Anti-Smoking Act, which came into force on 31.5.17. As of January 1, 2017, the hospital cancelled the sale of all tobacco products on its premises and thus became one of the hospitals that publicly present themselves as non-smoking. We want our hospital to be not only a place of treatment for diseases but also a center for protecting the health of patients and our employees. Smoking is the most important remediable cause of morbidity and mortality. In accordance with valid legislation, smoking has not been allowed in our hospital since 16.3.1992 (only in designated areas). Since January 1, we have been meeting all the conditions of the Anti-Smoking Act and rank among non-smoking hospitals. Smoking is currently only allowed on the hospital premises in a designated area on the second floor. We provide health care in all medical fields We are specialists in diseases of the cardiovascular and nervous system we offer state-of-the-art examination methods and often unique treatment procedures in the Czech Republic When making a diagnosis, we choose fast and least burdensome procedures for the patient Our experts have the highest qualifications in their field